marine drugs Article Biotechnological Potential of Cold Adapted Pseudoalteromonas spp. Isolated from ‘Deep Sea’ Sponges Erik Borchert 1, Stephen Knobloch 2, Emilie Dwyer 1, Sinéad Flynn 1, Stephen A. Jackson 1, Ragnar Jóhannsson 2, Viggó T. Marteinsson 2, Fergal O’Gara 1,3,4 and Alan D. W. Dobson 1,* 1 School of Microbiology, University College Cork, National University of Ireland, Cork T12 YN60, Ireland;
[email protected] (E.B.);
[email protected] (E.D.);
[email protected] (S.F.);
[email protected] (S.A.J.);
[email protected] (F.O.) 2 Department of Research and Innovation, Matís ohf., Reykjavik 113, Iceland;
[email protected] (S.K.);
[email protected] (R.J.);
[email protected] (V.T.M.) 3 Biomerit Research Centre, University College Cork, National University of Ireland, Cork T12 YN60, Ireland 4 School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth 6102, WA, Australia * Correspondence:
[email protected]; Tel.: +353-21-490-2743 Received: 22 February 2017; Accepted: 14 June 2017; Published: 19 June 2017 Abstract: The marine genus Pseudoalteromonas is known for its versatile biotechnological potential with respect to the production of antimicrobials and enzymes of industrial interest. We have sequenced the genomes of three Pseudoalteromonas sp. strains isolated from different deep sea sponges on the Illumina MiSeq platform. The isolates have been screened for various industrially important enzymes and comparative genomics has been applied to investigate potential relationships between the isolates and their host organisms, while comparing them to free-living Pseudoalteromonas spp. from shallow and deep sea environments.